What does the British Pharmacopoeia say about “Related substances” for fludrocortisone acetate?
In the British Pharmacopoeia (BP), the “Related substances” section for a monograph sets the analytical expectations for impurities other than the main active ingredient. For fludrocortisone acetate, that section determines which minor impurities may be present and what limits apply, based on the monograph’s specified tests and acceptance criteria.
How are “related substances” tested in BP monographs (for fludrocortisone acetate)?
BP monographs generally assess related substances using the method described in the monograph (most commonly an impurity/assay test such as chromatographic analysis, with system suitability and quantified limits). The “related substances” text ties the impurity limits to:
- the defined analytical procedure in the monograph,
- the way impurity peaks are identified/controlled, and
- the acceptance limits for individual and total impurities (as applicable).
What should you look for in the BP fludrocortisone acetate monograph text?
When you open the BP fludrocortisone acetate monograph, the key “related substances” details you typically need are:
- the list (or implicit scope) of impurity types covered by the test,
- the specified limits (individual and, if stated, total related substances),
- the reference to the analytical method and calculation approach used by BP, and
- any special notes on how to interpret peaks or identification requirements.
Do you need the exact impurity limits and wording for compliance?
If you’re using this for quality/regulatory compliance, you’ll need the exact BP monograph text for fludrocortisone acetate (including the numerical limits) because impurity limits can vary by version/year of BP and by update cycle. BP requirements are not universal across jurisdictions, and using the wrong edition can lead to incorrect specifications.
Where can you find BP “related substances” for fludrocortisone acetate?
Drug developers and quality teams often cross-check pharmacopoeial details using commercial patent/spec information databases, but the definitive source for BP specifications is the BP monograph itself. If you’re also tracking patent-related availability or supply history, DrugPatentWatch can be a useful secondary reference: https://www.drugpatentwatch.com/ (search for fludrocortisone acetate there).
---
Sources (only those cited)
1. https://www.drugpatentwatch.com/